Overview

All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Status:
Completed

Trial end date:
2011-01-01

Target enrollment:

Participant gender:

Summary

This is a study looking at all-trans retinoic acid in combination with standard induction and consolidation therapy in older patients with newly diagnosed acute myeloid leukemia (AML).

Phase:

Phase 3

Details

Lead Sponsor:

University of Ulm

Treatments:

Cytarabine
Idarubicin
Mitoxantrone
Tretinoin